Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 20 of 20 entries
View as:

Intraarterial Infusion of Autologous Bone Marrow in Diabetic Patients With Chronic Ischemia of Lower Limbs (CLI) no Revascularization

Phase: N/A Priority: Normal
NCT ID: NCT00987363 Org: User:
Start: 07/31/09 End: 03/31/13 Due: 03/31/14

Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Limb Ischemia (CLI).

Phase: N/A Priority: Normal
NCT ID: NCT01408381 Org: User:
Start: 01/31/11 End: 06/30/15 Due: 06/30/16

Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insulinized Diabetic Patients Type 2 With Critical Ischemia in Lower Limbs (CLI): Study of the Needs of Insulin

Phase: N/A Priority: Normal
NCT ID: NCT02287974 Org: User:
Start: 09/30/11 End: 07/31/18 Due: 07/31/19

Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response

Phase: N/A Priority: Normal
NCT ID: NCT02290041 Org: User:
Start: 02/08/17 End: 07/30/19 Due: 07/30/20

A Multicenter Phase I/II Clinical Trial to Evaluate Safety of Mesenchymal Stem Cell in Patients With Amyotrophic Sclerosis Lateral

Phase: N/A Priority: Normal
NCT ID: NCT02290886 Org: User:
Start: 07/31/14 End: 03/02/22 Due: 03/02/23

Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01257776 Org: User:
Start: 12/31/10 End: 07/31/15 Due: 07/31/16

Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence

Phase: N/A Priority: Normal
NCT ID: NCT02292628 Org: User:
Start: 10/31/13 End: 09/30/17 Due: 09/30/18

Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT02573272 Org: User:
Start: 06/30/15 End: 10/31/16 Due: 10/31/17

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01751243 Org: User:
Start: 01/31/13 End: 12/31/18 Due: 12/31/19

Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration

Phase: N/A Priority: Normal
NCT ID: NCT01745731 Org: User:
Start: 03/31/11 End: 12/31/15 Due: 12/31/16

Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.

Phase: N/A Priority: Normal
NCT ID: NCT01222039 Org: User:
Start: 06/30/10 End: 06/30/14 Due: 06/30/15

Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.

Phase: N/A Priority: Normal
NCT ID: NCT02033278 Org: User:
Start: 01/06/14 End: 04/21/20 Due: 04/21/21

Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.

Phase: N/A Priority: Normal
NCT ID: NCT02022514 Org: User:
Start: 11/30/13 End: 08/31/23 Due: 08/31/24

Clinical Trial With MSC for Graft Versus Host Disease Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02687646 Org: User:
Start: 02/20/17 End: 01/21/22 Due: 01/21/23

Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04630288 Org: User:
Start: 07/02/19 End: 12/31/20 Due: 12/31/21

Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01745783 Org: User:
Start: 01/31/13 End: 06/30/20 Due: 06/30/21

Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.

Phase: N/A Priority: Normal
NCT ID: NCT01454323 Org: User:
Start: 12/31/10 End: 02/28/15 Due: 02/28/16

Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01056471 Org: User:
Start: 01/31/10 End: 06/30/15 Due: 06/30/16

Application of Cell Regeneration Therapy With Mesenchymal Stem Cells From Adipose Tissue in Critical Chronic Ischemic Syndrome of Lower Limbs (CLI) in Nondiabetic Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01745744 Org: User:
Start: 02/28/11 End: 07/31/18 Due: 07/31/19

Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01765244 Org: User:
Start: 01/17/14 End: 01/14/21 Due: 01/14/22